Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.16
+0.15 (0.45%)
Nov 18, 2026, 1:05 PM EST - Market open
HRMY Market Cap
HRMY has a market cap or net worth of $1.95 billion as of November 18, 2026. It is the 6,518th most valuable company in the world and the 1,738th biggest in the United States. Its market cap has decreased by 0.53% in one year.
Market Cap
1.95B
Enterprise Value
1.33B
1-Year Change
-0.53%
Global Rank
Country Rank
#1,738 United States
Category
ChartMarket Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.95B, an increase of 322.37%. That is a compound annual growth rate of 25.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.95B | -9.65% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.06B |
| Immunome | 2.03B |
| Biohaven | 2.00B |
| Trevi Therapeutics | 1.93B |
| Septerna | 1.90B |
| Vera Therapeutics | 1.89B |
| Maravai LifeSciences Holdings | 1.89B |
| Fortrea Holdings | 1.89B |